StockWatch
·

UPL Limited

BSE: 512070

P/L Snapshot

Q1 FY2027 · standalone

vs Q4 FY2026
Revenue
1.5K
-5.2%
Expenditure
1.4K
+25.0%
Net Profit
89.00
-75.2%
OPM %
3.36%
-5.49pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00606.481.2K1.8K2.4KQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027

Price Chart

Latest News

Board Meeting3 Aug, 3:18 pm

UPL Q1: consol loss narrows to ₹73 Cr, revenue +10% YoY as deleveraging cuts finance cost

UPL's consolidated Q1 FY27 revenue rose 10.5% YoY to ₹10,181 Cr (from ₹9,216 Cr), but the Group still posted a net loss of ₹73 Cr for the period — roughly half the ₹176 Cr loss a year ago. The composition matters: profit attributable to owners of the parent swung positive to ₹10 Cr from an ₹88 Cr loss, while the ₹83 Cr loss now sits with non-controlling interests. Basic EPS was ₹0.12. Sequentially revenue fell 44.5% from ₹18,335 Cr, but that is agrochemical seasonality (the Jan–Mar Rabi quarter is the year's strongest, Apr–Jun the weakest), not a slowdown; QoQ should not be read as the story here. The swing to a narrower loss is led by deleveraging: finance costs dropped to ₹852 Cr from ₹1,007 Cr YoY (−15%), the clearest evidence the debt-reduction campaign we flagged pre-result is feeding through. Crop protection revenue grew 5.7% to ₹7,659 Cr and Seeds & Post-harvest 24.6% to ₹1,750 Cr; total segment EBIT was ₹1,110 Cr vs ₹985 Cr. One caveat on the loss-narrowing: other income carries a one-off ₹55 Cr Bombay High Court insurance arbitral award — strip it (the year-ago period had no equivalent) and the underlying loss is closer to ₹128 Cr, so the ~58% reported loss-narrowing overstates; the adjusted narrowing is nearer ~27%. Net margin improved (−0.7% vs −1.9% YoY) while operating margin held around 16%. Against the bar we set in our preview — ₹11,700–12,100 Cr revenue and +14–18% EBITDA — the print missed: revenue landed 13–16% below and EBITDA was broadly flat, so management's own 14–18% EBITDA guidance was not met this quarter, though the 10–14% revenue-growth guide was met at its low end. Street had built the FY27 thesis on ~72% consolidated profit growth; a still-loss-making Q1 is a soft (if seasonally weakest) start. On the corporate front, the Composite Scheme of Arrangement (UPL SAS amalgamation, appointed date April 1, 2026) received BSE/NSE observation letters on July 29 but has no P&L effect yet, pending NCLT and shareholder approvals; the $1 Sustainable Tech acquisition and the Bioplanta stake divestment are immaterial. Standalone, revenue fell 15.8% YoY to ₹1,397 Cr with PAT of ₹89 Cr (vs ₹122 Cr) — the standalone entity is a small slice of the Group, so the consolidated picture governs.

3 Aug 2026, 03:18 pm

Corporate Events

Board MeetingUPL
2026
6Aug

Board Meeting

The 42nd Annual General Meeting ("AGM") of UPL Limited has b…

BSE Filing
Board MeetingUPL
2026
3Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing
DividendUPL
2026
17Jul

₹6 / share

BSE Filing
DividendUPL
2025
11Jul

₹300 / share

BSE Filing
Board MeetingUPL
2024
11Nov

Board Meeting

consider and approve and take on record the unaudited standa…

BSE Filing
Board MeetingUPL
2024
13May

Board Meeting

Consider and approve the audited standalone and consolidated…

BSE Filing
Board MeetingUPL
2024
2Feb

Board Meeting

Consider and approve unaudited standalone and consolidated f…

BSE Filing
Board MeetingUPL
2023
22Dec

Board Meeting

Proposal of fund raising by issue of equity shares

BSE Filing